Corporate Social Responsibility in the pharmaceutical industry



What lies ahead in the research into Corporate Social Responsibility (CSR) in the Pharmaceutical Industry? This article analyzes the topics now being studied, the types of research already undertaken and obvious gaps that have to be filled for its development. To this end, we reviewed the investigations conducted in the 2000-2020 period in the highest-impact journals (according to Journal Citation Report - JCR), through a search in Web of Science. There are various reasons for organizations to formally assume CSR; there are several definitions of the concept and there are different ways to understand it within the environment of the Pharmaceutical Industry. The need to incorporate CSR strategies and programs designed for this type of industry is generally accepted, nevertheless, the main conclusions are unfortunately that the industry still shows a superficial attitude to CSR, and on the other hand that third parties such as the State will have to become involved. The role of the consumer and the internationalization of pharmaceutical companies are also of paramount importance.


Corporate Social Responsibility, Pharmaceutical Industry, Stakeholders


Abraham, J. (2002). The pharmaceutical industry as a political player. The Lancet,360(9344), 1498-1502.

Ahen, F. (2017). Responsibilization and MNC-stakeholder engagement: Who engages whom in the pharmaceutical industry? In R. E. Freeman, J. Kuhala, & S. Sachs (Eds.), Stakeholder engagement: Clinical research cases. (Vol. 46, pp. 87-112). Springer.

Álvarez, C., & Urbano, D. (2011). Una década de investigación basada en el GEM: Logros y retos (A decade of GEM research: Achievements and challenges). Academia Revista Latinoamericana de Administración (46), 16-37.

Becchetti, L., Ciciretti, R., Hasan, I., & Kobeissi, N. (2012). Corporate social responsibility and shareholder’s value. Journal of Business Research, 65(11), 1628-1635.

Benn, S., Todd, L., & Pendleton, J. (2010). Public relations leadership in corporate social responsibility. Journal of Business Ethics, 96(3), 403-423.

Boulouta, I., & Pitelis, C. N. (2014). Who needs CSR? The impact of corporate social responsibility on national competitiveness. Journal of Business Ethics, 119(3), 349-364.

Bowen, H. R. (1953). Social responsibilities of the businessman (1st ed.). Harper & Brothers.Carroll, A. B. (1979). A three-dimensional conceptual model of corporate performance. Academy of Management Review, 4(4), 497-505.

Class, J. (2012). Emerging markets and differential pricing policies: A question of global health? Journal of Commercial Biotechnology 18(4), 40-43.

Chan, W.; Cheah, J., & Montanheiro, L. (2016). Corporate social responsibility in the pharmaceutical industry. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 175-204). Edward Elgar Publishing Limited.

Cheah, E. T., Chan, W. L., & Chieng, C. L. L. (2007). The corporate social responsibility of pharmaceutical product recalls: An empirical examination of U.S. and U.K. markets. Journal of Business Ethics, 76(4), 427-449.

Commission des Communautés Européennes (C.C.E.) (2001). Livre vert.Protnotivoir un cadre eut opeen pour la responsabilité sociale des enterprises.

Coombs, W., & Holladay, S. (2012). Managing corporate social responsibility: A communication approach (1st ed.). Wiley-Blackwell.

Cook, L., LaVan, H., & Zilic, I. (2018). An exploratory analysis of corporate social responsibility reporting in U.S. pharmaceutical companies. Journal of Communication Management, 22(2), 197-211.

Crommelin, D., Stolk, P., Besancon, L., Shah, V., Midha, K., & Leufkens, H. (2010). Pharmaceutical sciences in 2020. Nature Reviews Drug Discovery, 9, 99-100.

Davis, K. (1967). Understanding the social responsibility puzzle. Business Horizons,10(4), 45-51.

Demir, M., & Min, M. (2019). Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry. Sustainability Accounting. Management and Policy Journal, 10(2), 333-364.

Duque, Y., Cardona, M., & Rendón, J. (2013). Responsabilidad social empresarial: Teorías, índices, estándares y certificaciones. Cuadernos de Administración-Universidad del Valle, 29(50), 196-206.

Egri, C. P., & Ralston, D. A. (2008). Corporate responsibility: A review of international management research from 1998 to 2007. Journal of International Management, 14(4), 319-339.

Elms, H., Berman, S., & Wicks, A. (2002). Ethics and incentives: An evaluation and development of stakeholder theory in the health care industry. Business Ethics Quarterly, 12(4), 413-432.

Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. The Journal of Infectious Diseases, 189(5), 930–937.

Finegold, D.L., Bensimon, C.M., Daar, A.S., Eaton, M.L., Godard, B., Knoppers, B.M., Mackie, J.E., & Singer, P.A. (2005). BioIndustry Ethics (1st ed.). Elsevier Academic Press.

Frederick, W. (1960). The growing concern over business responsibility. California Management Review, 2(4), 54-61.

Friedman, M., (1970, September 13). The social responsibility of business is to increase its profits. The New York Times Magazine, 1-6.

Fort, T. (2014). The paradox of pharmaceutical CSR: The sincerity nexus. Business Horizons, 57(2), 151-160.

Gallagher, J. A., & Goodstein, J. (2002). Fulfilling institutional responsibilities in health care: Organizational ethics and the role of mission discernment. Business Ethics Quarterly, 12(4), 433.

Gambardella, A. (1995). Science and innovation: The US pharmaceutical industry during the 1980s (1st ed.). Cambridge University Press.

Ghormley, E. & Falconi, T. (2010). Communicating responsibility: Capstone research (prepared for NYU M.S. in PR & CC).

Givel, M. (2013). Modern neoliberal philanthropy: motivations and impact of Pfizer Pharmaceutical’s corporate social responsibility campaign. Third World Quarterly,34(1), 171-182.

Goldacre, B. (2012). Bad pharma: How drug companies mislead doctors and harm patients(1st ed.). Fourth Estate.

Görpe, S., & Oksuz, B. (2016a). Corporate social responsibility in the Turkish pharmaceutical industry. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 251-269). Edward Elgar Publishing Limited.

Görpe, S., & Oksuz, B. (2016b). Corporate social responsibility as concept and activity: an overview. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 17-31). Edward Elgar Publishing Limited.

Guthey, E., & Morsing, M. (2013). CSR and the mediated emergence of strategic ambiguity. Journal of Business Ethics, 120(4), 555-569.

Hansen, SO. (1982). Studies in internationalisation of the pharmaceuticals industry – A taxonomic approach. [Doctoral thesis]. Åbo Akademi University.

Iñesta, A., & Oteo, L. (2011). The pharmaceutical industry and the sustainability of healthcare systems in developed countries and in Latin America. Ciência & Saúde Coletiva, 16(6), 2713-2724.

International Organization for Standarization (2010). Guidance on social responsibility (ISO 26000:2010).

Khaleel, M., Chelliah, S., Rauf, S., & Jamil, M. (2017). Impact of perceived corporate social responsibility on attitudes and behaviors of pharmacists working in MNCs. Humanomics, 33(4), 453-469.

Kolk, A. (2016). The social responsibility of international business: From ethics and the environment to CSR and sustainable development. Journal of World Business, 51(1), 23-34.

Leisinger, K. M. (2009). Corporate responsibilities for access to medicines. Journal of Business Ethics, 85(S1), 3-23.

Leisinger, K. M. (2005). The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation. Business Ethics Quarterly. 15(4), 577-594.

Mehralian, G., Nazari, J. A., Zarei, L., & Rasekh, H. R. (2016). The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM. Journal of Cleaner Production. 135, 689-698.

Mögele, B., & Tropp, J. (2010). The emergence of CSR as an advertising topic: A longitudinal study of German CSR advertisements. Journal of Marketing Communications, 16(3), 163-181.

Min, M., Desmoulins-Lebeault, F., & Esposito, M. (2017). Should pharmaceutical companies engage in corporate social responsibility? Journal of Management Development, 36(1), 58-70.

Nussbaum, A. (2009). Ethical corporate social responsibility (CSR) and the pharmaceutical industry: A happy couple? Journal of Medical Marketing, 9(1), 67-76.

O’Riordan, L., & Fairbrass, J. (2008). Corporate social responsibility (CSR): Models and theories in stakeholder dialogue. Journal of Business Ethics, 83(4), 745-758.

Osterath, B. (2014, March 23). The drug divide: Concerns grow in the US over generics produced in India. DW.

Palazzo, G., & Scherer, A. (2006). Corporate legitimacy as deliberation: A communicative framework. Journal of Business Ethics, 66(1),71-88.

Pisano, G. (2006). Science business: The promise, the reality, and the future of biotech (1st ed.). Harvard Business Press.

Price Water House Coopers (2009). Pharma 2020: Challenging business models. Which path will you take?

Rodríguez, P., Siegel, D. S., Hillman, A., & Eden, L. (2006). Three lenses on the multinational enterprise: Politics, corruption, and corporate social responsibility. Journal of International Business Studies, 37(6), 733-746.

Rusu, A., Kuokkanen, K., & Heier, A. (2011). Current trends in the pharmaceutical industry – A case study approach. European Journal of Pharmaceutical Sciences44(3), 437–440.

Shamir, R. (2008). The age of responsibilization: On market-embedded morality. Economy and Society, 37(1), 1-19.

Sillup, G., Makowska, M., & Porth, S. (2017). Ethical issues affecting the pharmaceutical industry-a comparison of newspaper coverage in the U.S. and Poland. Acta Poloniae Pharmaceutica - Drug Research, 74(4), 1301-1312.

Strand, R., Freeman, R. E., & Hockerts, K. (2015). Corporate social responsibility and sustainability in Scandinavia: An overview. Journal of Business Ethics, 127(1), 1-15.

Suchanek, A., & Lin-Hi, N. (2007). Corporate responsibility in the research-based pharmaceutical industry. Jahrbucher Fur Nationalokonomie Und Statistik, 227(5-6), 547-562.

Thorsteinsdóttir, H., Ovtcharenko, N., & Kohler, J. C. (2017). Corporate social responsibility to improve access to medicines: the case of Brazil. Globalization and Health 13(10), 1-12.

Vanhamme, J., & Grobben, B. (2009). Too good to be true! The effectiveness of CSR history in countering negative publicity. Journal of Business Ethics, 85(2), 273–83.

World Commission on Environment and Development (WCED) (1987). Our common future. The Brundtland Report. United Nations, General Assembly.

World Health Organization (2012). Why is good governance relevant to the pharmaceutical public sector?

Zhao, H., Zhangb, F., & Kwonc, J. (2017). Corporate social responsibility research in international business journals: An author co-citation analysis. International Business Review, 27(2), 389-400.